Related Experiment Videos
Chronic transfusions in patients with sickle cell disease. Indications and problems
The American Journal of Pediatric Hematology/Oncology
|January 1, 1985
Summary
Chronic transfusions are standard for preventing recurrent strokes in sickle cell disease patients. Proactive transfusions may prevent organ damage and reduce mortality in hemoglobin SS disease.
Area of Science:
- Hematology
- Neurology
- Pediatrics
Background:
- Sickle cell disease (SCD) carries high mortality and morbidity risks.
- Stroke is a common complication, with high recurrence rates.
- Current practice uses transfusions post-stroke to prevent recurrence.
Purpose of the Study:
- To evaluate the efficacy of chronic transfusions in preventing primary stroke and organ damage in SCD.
- To explore proactive transfusion as an alternative to conservative management.
Main Methods:
- Review of clinical studies on chronic transfusion efficacy.
- Analysis of the natural history of hemoglobin SS disease.
- Assessment of recent advances in chelation therapy.
Main Results:
- Clinical studies confirm chronic transfusion prevents stroke recurrence.
- Advances in chelation therapy mitigate risks of iron overload from transfusions.
Conclusions:
- Chronic transfusions, initiated before stroke or organ damage, offer a viable alternative management strategy for SCD.
- Proactive transfusion can significantly improve outcomes and reduce long-term complications in sickle cell disease.